# EDGAR Filing Document

**Accession Number:** 0001559356
**File Stem:** 0001376474-26-000425
**Filing Date:** 2026-6
**Character Count:** 4808
**Document Hash:** c4c0bbcc39450486310d67223ee9b397
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001376474-26-000425.hdr.sgml**: 20260608

**ACCESSION NUMBER**: 0001376474-26-000425

**CONFORMED SUBMISSION TYPE**: 15-12G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260608

**DATE AS OF CHANGE**: 20260608

**EFFECTIVENESS DATE**: 20260608

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Biostax Corp.
- **CENTRAL INDEX KEY:** 0001559356
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 593226705
- **STATE OF INCORPORATION:** FL
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 15-12G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-54933
- **FILM NUMBER:** 261072385

**BUSINESS ADDRESS:**
- **STREET 1:** 2431 ALOMA AVE #124
- **CITY:** WINTER PARK
- **STATE:** FL
- **ZIP:** 32792
- **BUSINESS PHONE:** (888) 613-8802

**MAIL ADDRESS:**
- **STREET 1:** 2431 ALOMA AVE #124
- **CITY:** WINTER PARK
- **STATE:** FL
- **ZIP:** 32792

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Immune Therapeutics, Inc.
- **DATE OF NAME CHANGE:** 20141103

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** TNI BIOTECH, INC.
- **DATE OF NAME CHANGE:** 20121001

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

FORM 15

**CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.**

Commission File Number: 000-54933

**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BIOSTAX CORP.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;** 

(Exact name of registrant as specified in its charter)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2431 Aloma Ave., Suite 124, Winter Park, Florida 32792&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel: 888-391-9355&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

<u>Florida </u> <u>59-3226705 </u> <br> (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

(Title of each class of securities covered by this Form)

______________________________________________________________________________________

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)□ Rule 12g-4(a)(2)□ <br> Rule 12h-3(b)(1)(i) □ Rule 12h-3(b)(1)(ii) 🗷 <br> Rule 15d-6□ Rule 15d-22(b) □

Approximate number of holders of record as of the certification or notice date: 296

The registrant has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports).&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Yes □&nbsp;&nbsp;&nbsp;&nbsp; No 🗷

The issuer has filed a Form 25, Notification of Removal from Listing and/or Registration under Section 12(b) of the Securities Exchange Act of 1934. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Yes 🗷&nbsp;&nbsp;&nbsp;&nbsp; No □

If 'Yes' is checked, state the date of filing: November 22, 2024

The registrant hereby certifies that it meets the eligibility requirements prescribed by the rule(s) selected above and is filing this Form 15 for the purpose of (check applicable box(es)):

🗷 Terminating the registration of a class of securities under Section 12(g) of the Exchange Act.

🗷 Suspending the duty to file reports under Section 13(a) or Section 15(d) of the Exchange Act pursuant to Rule 12g4(a)(2), 12h-3(b)(1)(i) or 12h-3(b)(1)(ii).

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;Date: May 22, 2026 | &nbsp;&nbsp;BIOSTAX CORP. | &nbsp;&nbsp;BIOSTAX CORP. |
|  | &nbsp;&nbsp;By: | &nbsp;&nbsp;/s/ Noreen McGurrin Griffin |
|  | &nbsp;&nbsp;Name: | &nbsp;&nbsp;Noreen McGurrin Griffin |
|  | &nbsp;&nbsp;Title: | &nbsp;&nbsp;Chief Executive Officer |

---